Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Go back to Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
(NASDAQ: VRDN) Delayed: 17.63 +1.00 (6.01%)
Previous Close $16.63    52 Week High
Open $16.93    52 Week Low
Day High $18.18    P/E N/A 
Day Low $16.93    EPS
Volume 2,549,627